Chile-based biotechnology company PhageLab secures $11M in funding. Nazca, Collaborative Fund, Water Lemon Ventures, and private investor Kevin Efrusy were among the backers.
With the...
CA-based biotechnology company Tr1X secures $75M in series A round funding. The Column Group led the investment, and Alexandria Ventures and NEVA SGR also...
NYC-based Biotechnology Company MimiVax Secures an Undisclosed Amount of Funding. Brain Tumour Investment Fund, a National Brain Tumour Society affiliate, participated in the round...
CA-based biotechnology startup CRISPR QC secures series A round funding. The deal's total value was not made public. The CRISPR Analytics Platform will continue...
OK-based biotechnology company Cadenza Bio secures $2.44M in series seed funding. Plains Ventures led the financing, with participation from the Oklahoma Life Science Fund,...
Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the closing of a $115 million Series C financing round. This...
Gate Bioscience, a biotechnology company developing a new class of small molecule medicines aiming to eliminate disease-causing proteins at their source, today announced the...
NEOK Bio, Inc., a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, announced that...
LambdaVision, a biotech innovator leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has...
Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series B financing. The...
